Advancing a First-in-Class Intranasal Neurosteroid for Concussion: Lessons from Clinical Development of a Direct-to-Brain Therapy
9:30 am - Wednesday 3rd February 2027
- Understand the scientific rationale for targeting concussion and traumatic brain injury through intranasal direct-to-brain delivery
- Explore the challenges of generating translational, safety, and clinical evidence to support progression of a novel neurological therapy into human studies
- Learn lessons from advancing a clinical-stage intranasal program, including regulatory strategy, development planning, and building confidence in direct CNS delivery
